Irina A. Bakhturina
Investor Relations Kontakt bei EVRAZ PLC
Profil
Irina A.
Bakhturina is currently the Director-Investor Relations at EVRAZ Plc since 2015.
Prior to this, she worked as the Director & Manager-Investor Relations at OTCPharm PJSC and as the Head-Investor Relations at Pharmstandard PJSC.
She completed her undergraduate degree at Moscow State University Lomonosov.
Aktive Positionen von Irina A. Bakhturina
| Unternehmen | Position | Beginn |
|---|---|---|
| EVRAZ PLC | Investor Relations Kontakt | 05.03.2015 |
Ehemalige bekannte Positionen von Irina A. Bakhturina
| Unternehmen | Position | Ende |
|---|---|---|
OTCPharm PJSC
 OTCPharm PJSC Pharmaceuticals: MajorHealth Technology OTCPharm PJSC engages in the production, marketing, promotion and wholesaling of pharmaceutical products. Its product portfolio brands include Arbidol, Pentalgin, Complivit, Flucostat, Aphobasolum, Codelac, Amixin, Acipol, Maxicold, Rinostop, Magnelis B6, Noopept, Asvitol, Ascophen-P, Next, Lactazar, Selmevit, Termicon, Lactonorm, Cyclovita, Cynocap, Univit, Nitrocor, Neosmectin, Klarisens, Azitrox, Gastrozol, Mycoderil. The company was founded on December 23, 2013 and is headquartered in Moscow, Russia. | Direktor/Vorstandsmitglied | - |
| FARMSTANDART OAO | Investor Relations Kontakt | - |
Ausbildung von Irina A. Bakhturina
| Moscow State University Lomonosov | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EVRAZ PLC | Non-Energy Minerals |
| Private Unternehmen | 2 |
|---|---|
Pharmstandard PJSC
 Pharmstandard PJSC Pharmaceuticals: MajorHealth Technology Pharmstandard PJSC engages in the production and wholesale distribution of pharmaceutical and medical products. It operates through the Production and Wholesale of Pharmaceutical Products, and Production and Wholesale of Medical Equipment segments. The company was founded on March 23, 2003 and is headquartered in Dologoprudny, Russia. | Health Technology |
OTCPharm PJSC
OTCPharm PJSC Pharmaceuticals: MajorHealth Technology OTCPharm PJSC engages in the production, marketing, promotion and wholesaling of pharmaceutical products. Its product portfolio brands include Arbidol, Pentalgin, Complivit, Flucostat, Aphobasolum, Codelac, Amixin, Acipol, Maxicold, Rinostop, Magnelis B6, Noopept, Asvitol, Ascophen-P, Next, Lactazar, Selmevit, Termicon, Lactonorm, Cyclovita, Cynocap, Univit, Nitrocor, Neosmectin, Klarisens, Azitrox, Gastrozol, Mycoderil. The company was founded on December 23, 2013 and is headquartered in Moscow, Russia. | Health Technology |
